Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.
About this episode
Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' urologic panels efficiently inform prognosis and individualized cancer treatment. The carefully curated panels fill the void between single gene assays and large NGS panels.
(00:32)
Could you provide our listeners with a little bit about yourself and your background, please?
(01:35)
Could you give us a brief overview of the newly developed urologic assays?
(03:51)
Can you talk a little bit more about what patients should have this testing?
(07:24)
Can you talk in more detail about the MayoComplete bladder and prostate panel?
(11:33)
How are these results used in patient care?
(16:10)
Is there anything else you would like to add?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab